Live Breaking News & Updates on Biopharma dive

Stay informed with the latest breaking news from Biopharma dive on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biopharma dive and stay connected to the pulse of your community

Healthy Returns: Biotech IPOs heated up, but haven't fully recovered

Biotech IPOs surged at the start of 2024, but the rest of the year will depend on Fed rate cuts. Meanwhile, doctors using VR and AI to hone their skills.

Mike-perrone , Arrivent-biopharma , Federal-reserve , Fractyl-health , Telomir-pharmaceuticals , Biopharma-dive , Vent-biopharma , Contineum-therapeutics , Arda-ural , Biotech-and-pharmaceuticals , Health-care-industry , Unitedhealth-group-inc

Acorda files for bankruptcy, reveals asset sale plan

Stalking horse bidder Merz Therapeutics could get rights to Acorda’s three marketed drugs if its $185 million proposal holds.

Germany , Finland , German , Ron-cohen , Acorda-therapeutics , Merz-group , Drug-administration , Us-supreme-court , Dive-brief , Scopia-capital-management , Civitas-therapeutics , Merz-therapeutics